Abstract
Co-trimoxazole is recommended for all children with human immunodeficiency virus. In this analysis, we evaluate trends in pediatric co-trimoxazole use and survival on co-trimoxazole in children using antiretroviral therapy (ART). We used data collected between January 1, 2006, and March 31, 2016, from the International Epidemiology Databases to Evaluate AIDS. Logistic regression was used to evaluate factors associated with using co-trimoxazole at ART initiation. Competing risk regression was used to assess factors associated with death. A total of 54113 children were included in this study. The prevalence of co-trimoxazole use at ART initiation increased from 66.5% in 2006 to a peak of 85.6% in 2010 and then declined to 48.5% in 2015-2016. A similar trend was observed among children who started ART with severe immunodeficiency. After adjusting for year of ART initiation, younger age (odds ratio [OR], 1.18 for <1 vs 1 to <5 years of age [95% confidence interval (CI), 1.09-1.28]), lower height-for-age z score (OR, 1.15 for less than -3 vs greater than -2 [95% CI, 1.08-1.22]), anemia (OR, 1.08 [95% CI, 1.02-1.15]), severe immunodeficiency (OR, 1.25 [95% CI, 1.18-1.32]), and receiving care in East Africa (OR, 8.97 vs Southern Afric...Continue Reading
References
Oct 1, 1984·The Journal of Pediatrics·W G WoodsL L Robison
Nov 24, 2004·Lancet·C ChintuUNKNOWN CHAP trial team
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Sarah WalkerUNKNOWN CHAP Team
May 1, 2010·Bulletin of the World Health Organization·Anand A DateCharlie Gilks
Jul 14, 2010·Journal of Pediatric Surgery·Samuel Rice-TownsendShawn J Rangel
Sep 16, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Rawiwan HansudewechakulUNKNOWN TREAT Asia Pediatric HIV Observational Database
Apr 12, 2011·Bulletin of the World Health Organization·Eleanor HutchinsonJustin Parkhurst
Aug 11, 2011·PloS One·Brian C ZanoniMargaret E Feeney
Oct 10, 2012·BMC Pediatrics·Digsu Negese KoyeBerihun Megabiaw Zeleke
Jan 1, 1991·Occupational Therapy in Health Care·M Pizzi, M Hinds-Harris
Oct 3, 2013·PloS One·Scott Dryden-PetersonShahin Lockman
Oct 9, 2013·Drug and Chemical Toxicology·Baskaran Thyagarajan, Sharad S Deshpande
Jan 3, 2014·The New England Journal of Medicine·Mutsawashe Bwakura-DangarembiziAndrew J Prendergast
Dec 17, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Manuel KollerUNKNOWN IeDEA, NISDI, PHACS and IMPAACT 219C studies
Dec 18, 2014·Journal of the International AIDS Society·Stephany N DudaUNKNOWN International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration
Jan 27, 2015·The Lancet Infectious Diseases·James A ChurchAndrew J Prendergast
Feb 5, 2015·HIV Medicine·A BamfordUNKNOWN (PENTA Steering Committee)
Aug 8, 2015·BMC Infectious Diseases·Aïda Mounkaila HarounaUNKNOWN IeDEA paediatric West African Study Group
Mar 24, 2016·BMC Medicine·Angela M CrookUNKNOWN ARROW Trial Team
Dec 1, 2018·Toxicology·Christopher M TimperleyVivek Suri